Latest
High Disinfection With Peracetic Acid May Reduce Risk of SARS-CoV-2 Spreading Following Endoscopy
No Significant Differences With Mavrilimumab vs Placebo in Outcomes of Patients With Severe COVID-19 Pneumonia, Hyperinflammation
MPR Weekly Dose #73: Interview with Dr Joshua Barocas
In-Hospital SARS-CoV-2 Mortality Declined Throughout Pandemic
Bariatric Surgery Cuts Cancer Risk With Obesity + Liver Disease
Decrease Seen in Suicide Rate in the United States
Several Racial/Ethnic-Minority Groups Underrepresented in Health Care Professions
A Conversation About Racial Disparities in Health Care
New Dosing Regimen Approved for Erbitux in Colorectal, Head and Neck Cancer
Lancet Authors Call for Improvement in Anal Cancer Screening Uptake
Persistent Viral Shedding Associated with Severe COVID-19 Disease
Preventive Nonopioid Analgesics Improve Children’s Postsurgical Pain Outcomes
Public Lost Trust in CDC During COVID-19 Crisis
Obesity Tied to Increased Mortality Overall in Patients With Cancer
COVID-19 Funeral Assistance Program Announced by White House
‘Possible Link’ Found Between AstraZeneca COVID-19 Vaccine, Rare Blood Clots
TAK-101 May Prevent Gluten-Induced Immune Activation in Celiac Disease
Increasing Expenses for Privately Insured Patients Seeking Neurologic Diagnostic Services
Brain MRI and EEG Clues to COVID-19-Related Encephalopathy
Featured Content
-
Review of Barriers to Colorectal Cancer Screening in Hard-to-Reach Populations
The COVID-19 pandemic sheds new light on existing access challenges in preventive health care. -
Bariatric Surgery in Cirrhosis: A Clinical Practice Update From the AGA
The American Gastroenterological Association (AGA) has issued a clinical practice update regarding bariatric surgery in cirrhosis. -
Opioids and IBD: Current Challenges
Initiation of opioid use during a flare of symptoms can eventually lead to chronic opioid use (COU), which can have detrimental effects on a patient’s IBD, as well as their overall clinical health. -
Gut Microbiome: A New Mechanism to Monitor Response to Biologics?
The gut microbiome is complex within irritable bowel disease (IBD), and its disruption may be a potential contributing factor in the pathogenesis of IBD. -
HIV and Inflammatory Bowel Disease: A Unique Patient Population
The authors review gut dysfunction and microbiota changes during HIV infection and IBD and discuss how they may induce a dysfunctional mucosal barrier, dysbiosis, and changes on the cellular level, including monocytes, macrophages, and dendritic cells.
OAGB and RYGB Weight Loss Procedures Feature Similar Early Safety Profiles
The investigators aimed to report on early experience with OAGB compared to RYGB in terms of complication rates.
COVID-19 Vaccine Efficacy After First Dose: Pfizer, Moderna, AstraZeneca
New data about Pfizer COVID-19 efficacy after the first dose suggests high efficacy, raising questions about potential alternative dosing schedules.
Updates to the 2021 Adult Immunization Schedule
The ACIP emphasizes the importance of routine vaccinations during the pandemic to prevent diseases.
Bariatric Surgery and Colorectal Cancer: Is There a Risk?
C. Andrew Kistler, MD, PharmD, examines existing data about bariatric surgery and the risk for subsequent colorectal cancer development.
Controversy: Protecting People Who Use Drugs During COVID-19
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
-
Loading...
-
Loading...
